Data gathered: April 15
Alternative Data for Quest Diagnostics
About Quest Diagnostics
Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses.
| Price | $168.00 |
| Target Price | Sign up |
| Volume | 1,720,000 |
| Market Cap | $18.6B |
| Year Range | $144 - $176.09 |
| Dividend Yield | 1.95% |
| PE Ratio | 21.85 |
| Analyst Rating | 75% buy |
| Earnings Date | April 22 '25 |
| Industry | Health Care Services |
In the news
 |
Quest Diagnostics price target raised by $8 at BofA, here's whyApril 14 - Thefly.com |
 |
Mizuho Issues Positive Forecast for Quest Diagnostics (NYSE:DGX) Stock PriceApril 11 - ETF Daily News |
Drug Screening Market Report 2025 | CAGR of 15% Projected Through 2025-2029 | Laboratory Corp., Quest Diagnostics, OraSure Technologies, Alfa Scientific Designs, and Abbott Laboratories Lead the IndustryApril 11 - GlobeNewswire |
|
 |
Quest Diagnostics Incorporated (NYSE:DGX) Receives $180.60 Average Price Target from BrokeragesApril 10 - ETF Daily News |
 |
DGX Stock Gains Following the Launch of New AD-Detect Blood TestApril 10 - Yahoo |
|
O Shaughnessy Asset Management LLC Has $649,000 Stock Position in Quest Diagnostics Incorporated (NYSE:DGX)April 10 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 2.44B | 1.68B | 762M | 226M | 362M | 2.300 |
| Q2 '24 | 2.35B | 1.59B | 760M | 229M | 379M | 2.350 |
| Q1 '24 | 2.32B | 1.6B | 728M | 194M | 338M | 2.040 |
| Q4 '23 | 2.25B | 1.55B | 696M | 192M | 307M | 2.150 |
| Q3 '23 | 2.26B | 1.54B | 714M | 225M | 361M | 2.220 |
Insider Transactions View All
| Davis J. E. filed to sell 130,471 shares at $169.6. April 4 '25 |
| Davis J. E. filed to sell 127,623 shares at $169.6. April 4 '25 |
| Davis J. E. filed to sell 130,738 shares at $168.7. April 4 '25 |
| Davis J. E. filed to sell 162,333 shares at $169.6. April 4 '25 |
| Davis J. E. filed to sell 131,322 shares at $167.9. April 4 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Gil Cisneros |
Feb 12, 25 | Sell | $1K - $15K |
| Ro Khanna |
Dec 6, 24 | Buy | $1K - $15K |
| Earl Blumenauer Democrat |
May 4, 24 | Sell | $1K - $15K |
Read more about Quest Diagnostics (DGX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Quest Diagnostics?
The Market Cap of Quest Diagnostics is $18.6B.
What is Quest Diagnostics' PE Ratio?
As of today, Quest Diagnostics' PE (Price to Earnings) ratio is 21.85.
When does Quest Diagnostics report earnings?
Quest Diagnostics will report its next earnings on April 22 '25.
What is the current stock price of Quest Diagnostics?
Currently, the price of one share of Quest Diagnostics stock is $168.00.
How can I analyze the DGX stock price chart for investment decisions?
The DGX stock price chart above provides a comprehensive visual representation of Quest Diagnostics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Quest Diagnostics shares. Our platform offers an up-to-date DGX stock price chart, along with technical data analysis and alternative data insights.
Does DGX offer dividends to its shareholders?
Yes, Quest Diagnostics (DGX) offers dividends to its shareholders, with a dividend yield of 1.95%. This dividend yield represents Quest Diagnostics' commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Quest Diagnostics in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Quest Diagnostics?
Some of the similar stocks of Quest Diagnostics are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.
.